Demonstrators gathered outside Google DeepMind's London office on Monday to accuse the company of reneging on a key AI ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Dozens of protesters, organized by PauseAI, staged a mock trial outside Google DeepMind's London headquarters, accusing the ...

Activists staged a mock courtroom outside Google DeepMind, accusing the tech giant of backtracking on its AI safety pledge ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind CEO Demis Hassabis showed 60 Minutes Genie 2, an AI model that generates 3D interactive environments, which could be used to train robots in the not-so-distant future.

Image: Transport for London. Researchers at Google-owned DeepMind in the UK have developed AI that can store knowledge, such as a map, and use it to navigate a system as complicated as London's ...

The Menlo Park, Calif.-based company has signed a deal with a British eye hospital to use artificial intelligence to learn from the medical records of 1.6 million patients in London hospitals.

Google will investigate how DeepMind's technology can be taught to analyze scans for the two diseases --the diagnoses of which have been time-consuming efforts for eye doctors due to their complexity.